You can't win every day team. A bit of sour with the sweet.I've decided personally to hold (again) through this quarter. Haven't had the guts to pull-pin before any of the others for fear of missing out, and of course my fear has only grown as we've lined up so much for success near term. If we see another big sell-off, I'm going to use margin to buy the low. This is the strategy I used on the last dip, and though not very well timed given how low we went, I was able to sell late last week and make a very tidy profit. I would suggest it, for those that suffer from quarterly FOMO. The first time we do beat street expectations, I think we're going to blast off. That said it could be many quarters away. Until then though, tune into the OCS for a freshly dominant stance on our oils. We are now 11 of the 30 offerings on the oil front which is substantial. What's also of note is that HEXO is in second with 7 offerings. The other 40% of oil products are split between many players, none of which have more than a few at best. Though I appreciate this is not a linear indicator of our offering in Canada across all retail channels, I do think it's telling of our leadership in the gelcap side. I know I've harped a bit on this in the past, but I do think it's substantial with respect to our retail plan and leadership position. For a simple look at where industry is headed, just look at where we are focusing today. Bruce and co do a great job of anticipating the market, and that's why I'm so at ease leaving my money on the table. The other piece to the oil story is that we have a lot of it. Anyone who's been referencing the websites even casually will notice that we very rarely go out of stock on these skews, and when we do they're back in stock almost immediately. Flower is lower margin, bulky, and less shelf-stable. Once edibles and vapes hit, flower will fall off dramatically. I'll bet we're 25% flower re sales by mid 2020 if I had to guess. Anyways, ramblings on a red day! GLTA